A DAD-of-two with a stage four brain tumour has now returned to work after pioneering treatment abroad stabilised his condition.

Steve White, from Eccleston, was diagnosed with an aggressive life-threatening tumour called glioblastoma multiforme wild-type in July last year.

He did not realise he was living with the life limiting condition until he suffered three seizures while away celebrating his 16th wedding anniversary with his wife Katheryn.

Fundraising efforts, which included Steve and friends cycling from Lands End to John O’Groats, raised more than £79,000 for the 44-year-old to have treatment in India called Dendritic Cell therapy.

After several visits to a clinic in India, Steve’s scans have shown that the tumour, which is fast acting, is now stable.

Steve said: “I started immunotherapy in India in January.

“I’ve had 12 infusions and been over there 14 times but it is all worth it because in my April, July and October scans I have had regression each time and I’m stable.

“This isn’t a cure but it’s a way of extending my life so I can feel good in myself, which I do, and be with my wife Katheryn and two sons Joseph, 16 and Sam – which is what matters.

“I am genuinely thankful to wake up each morning, especially when I’m walking my six-year-old Sam to school.

“I genuinely believe the generosity and support I have received from our local community is why I am still am still here and feeling so well, so thank you from the bottom of my heart to every single person who has supported me.

“I have also just started a phased return to work, at Aggregate Industries, who have been fantastic for me and my family over the last 16 months.

“It has cost a lot of money to go back and forth so far, around £30,000 mostly through flights.

“But I am so grateful to be able to fight this and hope to raise more through more fundraising events this year – including a ball in March.”

Steve is now helping others in the community in similar situations to look at alternative treatments and is involved with the Policy Involvement Group at the Brain Tumour Charity, which researches improved treatment options.